Yichang Tianren Pharmaceutical Co., Ltd., established on 2004-08-05, The scope of business includes the manufacture of APIs,Sales(The above business scope shall be operated according to the content verified in the license or approval document,Those who have not obtained relevant valid permits or approval documents,Not allowed to operate);Medical Technology Development,technology transfer,Technical Services,technical consulting;Drug Testing Service;Chemical product sales(Does not contain dangerous explosive chemicals and varieties that are restricted by the state);Operating and acting as an agent for the import and export of various commodities and technologies(Except for commodities and technologies that the state restricts the company to operate or prohibits export);operating incoming material processing and"Three to one make up"business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)++

Raptor Pharmaceuticals Corp. operates as a development stage biotechnology company in the United States. The company engages in the discovery, research, and preclinical development of drug candidates and drug-targeting platforms for the treatment of various brain disorders and neurodegenerative diseases, genetic disorders, and cancer through the proprietary use of receptor-associated proteins and mesoderm development proteins. Its clinical-stage products include DR Cysteamine, which is in Phase IIb clinical trail for the treatment of nephropathic cystinosis or cystinosis; and in Phase IIa clinical trail for the treatment of non-alcoholic steatohepatitis. The company also develops Convivia, a Phase IIa clinical trail product for the treatment of aldehyde dehydrogenase or ALDH2 deficiency; DR Cysteamine, which is in Phase II clinical trail for the treatment of Huntington's Disease; and Tezampanel and NGX 426 that is in Phase II clinical trail for the treatment of migraine, acute pain, and chronic pain. In addition, its preclinical development products comprise HepTide for the treatment of Hepatocellular Carcinoma and Hepatitis C; WntTide for the treatment of breast cancer; and NeuroTrans for the treatment of neurodegenerative diseases. The company has collaboration agreements with the University of California, San Diego for a clinical study of DR Cysteamine in juvenile patients with Non-Alcoholic Steatohepatitis and to study DR Cysteamine in patients with cystinosis. Raptor Pharmaceuticals Corp was founded in 2005 and is based in Novato, California.

Haikou Pharmaceutical Factory Co., Ltd., established on 1990-03-09, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Import and export;Technology Import and Export;Drug import and export;Drug Wholesale;Production of Class II Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:Non-residential real estate leases;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;property management;Chemical product sales(No licensed chemical products);Sales of Class II Medical Devices(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Henan Yawei Animal Pharmaceutical Co., Ltd., established on 2003-06-06, The business scope includes small-volume injections of veterinary drugs,powder,Premix,Powder,tablet,Granules,disinfectant(liquid)production and sales(Operate according to the validity period approved by the license);Engaged in the import and export of goods and technology.

Morinaga Milk Industry Co., Ltd. engages in the production and distribution of dairy products. Its operations are carried out through the following segments: Food Products and Others. The Food Products segment engages in the production and sale of milk, dairy-based beverages, yogurt, desserts, condensed milk, powdered milk, butter, cheese, ice cream, non-dairy beverages (juice, tea, coffee), and clinical liquid diets. The Others segment provides the real estate leasing services. It also engages in the manufacture and sale of animal feeds; design and construction of plant equipment. The company was founded on September 1, 1917 and is headquartered in Tokyo, Japan.

Chenzhou No. 1 People’s Hospital engages in the provision of medical emergency, scientific research & teaching, rehabilitation & health care, and nursing care services. The company was founded in 1907 and is headquartered in Chenzhou, China.

NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations segment operates in the divisions of oncology, pharma specialties and CnD. The International Formulations segment exports its FDF products from India to several international geographies either through its local partners or directly through its subsidiaries such as in Canada and Brazil. The Active Pharmaceutical Ingredients segment is strategically important as it develops APIs for the captive consumption of many of NATCO's critical FDF products in addition to supplying to direct customers. The company was founded by Venkaiah Chowdary Nannapaneni in 1981 and is headquartered in Hyderabad, India.

Weihai Haotong Pharmaceutical Technology Co., Ltd., established on 2012-08-20, Business scope includes pharmaceutical products,cosmetic,Technology research and development of pharmaceutical intermediates,technical consulting,Transfers and Services;Class I medical device,cosmetic,Packaging Materials,Chemical Products(Does not contain dangerous goods)Sales(law,Except for items prohibited by administrative regulations,Items restricted by laws and administrative regulations can only be operated after obtaining a license).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Part of Horizon Therapeutics Plc, Horizon Orphan LLC (doing business as TranscendRare) is an American company located in Lake Forest, IL. The firm develops pharmaceuticals.

Weihai Henderson Information Technology Development Co., Ltd., established on 2015-04-10, The scope of business includes the development of computer software and automation systems,Sales,Technical service and technology transfer;Information consultation for science and technology projects;Economic Information Consulting;Business Management Consulting.(The scope of business is subject to the approval of the administration for industry and commerce)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Liaoning Tongzheng Testing Co., Ltd., established on 2015-05-13, Business scope includes licensed projects:Inspection and testing service,Quality and safety inspection of agricultural products,Indoor environment detection,Certification Services(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Computer System Services,software development,Information system integration service,Information Technology Consulting Services,Information system operation and maintenance services,Intelligent control system integration,IoT application service,Internet of Things Technology Services,Internet of things technology research and development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Jiangxi Huangshanghuang Group Food Co., Ltd. engages in the development, production, and sale of marinated meat products, cold dishes, quick-consumption foods and rice products. It provides duck, chicken, goose, pork, beef, mutton, vegetable, instant congee and moon cake products. The company was founded on April 1, 1999 and is headquartered in Nanchang, China.